Stephen D. Barr

1.9k total citations
35 papers, 1.4k citations indexed

About

Stephen D. Barr is a scholar working on Immunology, Molecular Biology and Virology. According to data from OpenAlex, Stephen D. Barr has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Molecular Biology and 13 papers in Virology. Recurrent topics in Stephen D. Barr's work include HIV Research and Treatment (13 papers), interferon and immune responses (10 papers) and HIV/AIDS drug development and treatment (5 papers). Stephen D. Barr is often cited by papers focused on HIV Research and Treatment (13 papers), interferon and immune responses (10 papers) and HIV/AIDS drug development and treatment (5 papers). Stephen D. Barr collaborates with scholars based in Canada, United States and Ethiopia. Stephen D. Barr's co-authors include Frederic D. Bushman, Lashitew Gedamu, James R. Smiley, Jeremy Leipzig, Angela Ciuffi, Sridhar Hannenhalli, Christian Hoffmann, Mary K. Lewinski, Jenna N. Kelly and Katherine Plewes and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Stephen D. Barr

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen D. Barr Canada 16 580 414 351 350 284 35 1.4k
Daniel Santos Mansur Brazil 20 515 0.9× 948 2.3× 241 0.7× 642 1.8× 130 0.5× 40 1.7k
Irene Ramos United States 23 543 0.9× 1.0k 2.4× 203 0.6× 970 2.8× 121 0.4× 46 2.0k
John Hural United States 18 544 0.9× 804 1.9× 619 1.8× 414 1.2× 234 0.8× 35 1.6k
Megan Steain Australia 23 391 0.7× 518 1.3× 181 0.5× 688 2.0× 74 0.3× 54 1.6k
Kyoko Murakami Japan 21 406 0.7× 116 0.3× 115 0.3× 550 1.6× 146 0.5× 65 1.5k
Karen L. Denzler United States 12 275 0.5× 471 1.1× 289 0.8× 289 0.8× 166 0.6× 19 1.3k
G M Bahr Kuwait 22 584 1.0× 540 1.3× 189 0.5× 437 1.2× 55 0.2× 67 1.5k
Jillian M. Carr Australia 23 442 0.8× 413 1.0× 305 0.9× 262 0.7× 109 0.4× 72 1.7k
Lionel Berthoux Canada 24 931 1.6× 711 1.7× 1.4k 4.0× 494 1.4× 184 0.6× 54 2.1k
Anjali Joshi United States 23 556 1.0× 433 1.0× 830 2.4× 358 1.0× 151 0.5× 63 1.6k

Countries citing papers authored by Stephen D. Barr

Since Specialization
Citations

This map shows the geographic impact of Stephen D. Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Barr more than expected).

Fields of papers citing papers by Stephen D. Barr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Barr. The network helps show where Stephen D. Barr may publish in the future.

Co-authorship network of co-authors of Stephen D. Barr

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D. Barr. A scholar is included among the top collaborators of Stephen D. Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D. Barr. Stephen D. Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meer, Frank van der, M. John Gill, Deirdre L. Church, et al.. (2025). Early pandemic HIV-1 integration site preferences differ across anatomical sites. Communications Medicine. 5(1). 405–405.
2.
Renner, Tyler M., Kasandra Bélanger, Matthew Greig, et al.. (2023). Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles. Nature Communications. 14(1). 16–16. 7 indexed citations
3.
Barr, Stephen D., et al.. (2023). The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity. Biomolecules. 13(7). 1095–1095. 7 indexed citations
4.
Ndashimye, Emmanuel, et al.. (2023). Specialized DNA Structures Act as Genomic Beacons for Integration by Evolutionarily Diverse Retroviruses. Viruses. 15(2). 465–465. 2 indexed citations
5.
Rashu, Rasheduzzaman, Marina Ninkov, Michael R. D’Agostino, et al.. (2023). Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogens. PLoS Pathogens. 19(6). e1011485–e1011485. 11 indexed citations
6.
Barr, Stephen D., et al.. (2021). HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response. Viruses. 13(6). 1102–1102. 44 indexed citations
7.
Ha, Soon-Duck, et al.. (2018). Cathepsin B Plays a Key Role in Optimal Production of the Influenza A- Virus. PubMed. 7(1). 21 indexed citations
10.
McAllister, Robert G., et al.. (2014). Lentivector Integration Sites in Ependymal Cells From a Model of Metachromatic Leukodystrophy: Non-B DNA as a New Factor Influencing Integration. Molecular Therapy — Nucleic Acids. 3. e187–e187. 13 indexed citations
11.
Ha, Soon-Duck, et al.. (2011). Inhibition or deficiency of cathepsin B leads defects in HIV-1 Gag pseudoparticle release in macrophages and HEK293T cells. Antiviral Research. 93(1). 175–184. 12 indexed citations
12.
Woods, Matthew, Jenna N. Kelly, Li Xu, et al.. (2011). Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag. Retrovirology. 8(1). 95–95. 69 indexed citations
13.
Ciuffi, Angela & Stephen D. Barr. (2010). Identification of HIV integration sites in infected host genomic DNA. Methods. 53(1). 39–46. 20 indexed citations
14.
Barr, Stephen D., James R. Smiley, & Frederic D. Bushman. (2008). The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22. PLoS Pathogens. 4(2). e1000007–e1000007. 232 indexed citations
15.
Barr, Stephen D., Angela Ciuffi, Jeremy Leipzig, et al.. (2006). HIV Integration Site Selection: Targeting in Macrophages and the Effects of Different Routes of Viral Entry. Molecular Therapy. 14(2). 218–225. 73 indexed citations
16.
Barr, Stephen D., et al.. (2006). Identification, sequencing and expression of peroxidoxin genes from Leishmania aethiopica. Acta Tropica. 99(1). 88–96. 15 indexed citations
17.
Barr, Stephen D., et al.. (2006). Leishmania aethiopica: Identification and characterization of cathepsin L-like cysteine protease genes. Experimental Parasitology. 115(3). 283–290. 14 indexed citations
18.
Bushman, Frederic D., Mary K. Lewinski, Angela Ciuffi, et al.. (2005). Genome-wide analysis of retroviral DNA integration. Nature Reviews Microbiology. 3(11). 848–858. 316 indexed citations
19.
Barr, Stephen D. & Lashitew Gedamu. (2003). Role of Peroxidoxins in Leishmania chagasiSurvival. Journal of Biological Chemistry. 278(12). 10816–10823. 89 indexed citations
20.
Barr, Stephen D. & Lashitew Gedamu. (2001). Cloning and Characterization of Three Differentially Expressed Peroxidoxin Genes from Leishmania chagasi. Journal of Biological Chemistry. 276(36). 34279–34287. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026